Interleukin-1 and Interleukin-6 Activities are Increased in the Cerebrospinal Fluid of Patients with CNS Lupus Erythematosus and Correlate with Local Late T-Cell Activation Markers
- 1 February 1992
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 1 (2) , 111-117
- https://doi.org/10.1177/096120339200100209
Abstract
We examined cerebrospinal fluid (CSF) samples from 12 patients with SLE and active central nervous system (CNS) involvement for their levels of the following cytokines: interleukin- 1 (IL-1) by means of two different assays-the IL-1 responsive murine cell line LBRM 33-1a5 and an ELISA for IL-1 alpha; IL-2 by means of the CTLL cell line responsive to it; and interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) both determined by a specific ELISA. We found that SLE CSF had significantly higher levels of IL-1 and IL-6 than did those obtained at surgery from eight controls without inflammatory neurologic disease. IL-2 and TNF were not detectable in any of the CSF samples. We also studied the status of activation in CSF T cells using monoclonal antibodies against early (anti-IL-2R (CD25) and antitransferrin (CD71)), late (anti-T10) and very late (anti-VLA-1) activation antigens, and found increased percentages of T10-bearing (18 ± 2 vs 3 ± 0.7%) and VLA-1-bearing T cells (12 ± 2 vs 0.7 ± 0.2%) in SLE patients as compared to controls (both P < 0.01). Levels of IL-1 and IL-6 correlated with T10 and those of IL-1 correlated also with VLA-1. Markers of early T-cell activation did not differ in SLE and control CSF. Because of these findings we analysed the effect of recombinant IL,-I, IL-6 or normal CSF on normal T cells and found that they did not induce the expression of activation markers. However, incubation in SLE CSF caused CD25, T10 and VLA-1 activation markers to become significantly expressed on cultured normal T cells. This expression of T10 and VLA-1 was partially inhibited by pre-incubation in anti-human IL-1 alpha polyvalent antibody. Our findings suggest increased in situ production of IL- and IL-6 and perhaps other factors in CNS lupus that might condition T-cell activation in the CNS compartment. These findings could have pathogenetic significance.Keywords
This publication has 29 references indexed in Scilit:
- Elevated levels of interleukin‐6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system invol vementArthritis & Rheumatism, 1990
- Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factorEuropean Journal of Immunology, 1990
- Immunopathogenesis of the neuropsychiatric manifestations of systemic lupus erythematosusSpringer Seminars in Immunopathology, 1986
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Interleukin l and T Cell ActivationImmunological Reviews, 1982
- BINDING SITES FOR IMMUNE COMPONENTS IN HUMAN CHOROID PLEXUSArthritis & Rheumatism, 1981
- Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients.Journal of Clinical Investigation, 1980
- Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977Seminars in Arthritis and Rheumatism, 1979
- Lupus MeningitisAnnals of Internal Medicine, 1974
- SERUM AND CEREBRAL SPINAL FLUID COMPLEMENT AND SERUM AUTOANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUSMedicine, 1971